Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 22M | 22M |
| Cost of revenue | 11M | 10M |
| Gross profit | 11M | 12M |
| Research and development | 7M | 6M |
| Selling, general and administrative | 9M | 8M |
| Operating expenses | 16M | 15M |
| Operating income | −5M | −3M |
| Pre-tax income | −5M | −3M |
| Income tax | 240,000 | 386,000 |
| Net income | −5M | −3M |
| Earnings per share | −0.56 | −0.34 |
| Earnings per share, diluted | −0.56 | −0.34 |
| Weighted average shares | 9M | 9M |
| Weighted average shares, diluted | 9M | 9M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6M | 8M | 10M | 10M | 10M | 10M | 12M | 11M |
| Receivables | 2M | 3M | 3M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −2M | −995,000 |
| Depreciation and amortisation | 495,000 | 564,000 |
| Share-based compensation | 697,000 | 977,000 |
| Capital expenditure | 558,000 | 467,000 |
| Investing cash flow | −558,000 | −467,000 |
| Financing cash flow | −107,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 4M |
| 4M |
| 4M |
| — |
| — |
| Inventory | 6M | 6M | 6M | 6M | 6M | 6M | 7M | 7M |
| Current assets | 15M | 17M | 19M | 21M | 21M | 21M | 22M | 22M |
| Property, plant and equipment | 700,000 | 807,000 | 925,000 | 1M | 921,000 | 1M | 928,000 | 932,000 |
| Total assets | 18M | 20M | 23M | 24M | 25M | 25M | 25M | 24M |
| Current liabilities | 6M | 5M | 5M | 5M | 5M | 5M | 5M | 4M |
| Equity | 10M | 14M | 16M | 17M | 18M | 18M | 19M | 19M |
| Shares outstanding | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M |
| Shares issued | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M |
| −232,000 |